Pharmabiz

Novo Nordisk announces China’s Supreme People’s Court delivers positive ruling on semaglutide compound patent

Novo Nordisk announces China’s Supreme People’s Court delivers positive ruling on semaglutide compound patent: Bagsværd, Denmark Saturday, January 3, 2026, 17:00 Hrs [IST] Th ...
Pharmabiz

BioAtla and GATC Health announce $40 million SPV transaction to advance ozuriftamab vedotin into a registrational trial for 2L+ OPSCC

BioAtla and GATC Health announce $40 million SPV transaction to advance ozuriftamab vedotin into a registrational trial for 2L+ OPSCC: San Diego Saturday, January 3, 2026, 18:00 H ...
Pharmabiz

Corcept receives US FDA Complete Response Letter for relacorilant as a treatment for patients with hypercortisolism

Corcept receives US FDA Complete Response Letter for relacorilant as a treatment for patients with hypercortisolism: Redwood City, California Saturday, January 3, 2026, 14:00 Hrs ...
Pharmabiz

Xortx Therapeutics announces pioneering research on genome-wide pathogenic pathways in gout

Xortx Therapeutics announces pioneering research on genome-wide pathogenic pathways in gout: Calgary, Alberta Saturday, January 3, 2026, 13:00 Hrs [IST] Xortx Therapeutics Inc., a ...
Pharmabiz

Delcath Systems announces publication of subgroup analyses of phase 3 FOCUS study of Melphalan/Hepatic Delivery System in patients with unresectable metastatic uveal melanoma

Delcath Systems announces publication of subgroup analyses of phase 3 FOCUS study of Melphalan/Hepatic Delivery System in patients with unresectable metastatic uveal melanoma Queensbury, New York ...
Pharmabiz

Hoth Therapeutics expands oncology pipeline with dual patent filings establishing novel oncology dermatology IP platform

Hoth Therapeutics expands oncology pipeline with dual patent filings establishing novel oncology dermatology IP platform: New York Saturday, January 3, 2026, 16:00 Hrs [IST] Hoth ...